ELDN

Eledon Pharmaceuticals Inc.

Price

$3.55

return (12m)

35.50%

p/e

-6.10

p/bv

12.38

DIVIDEND YIELD

0.00%

ELDN price

Eledon Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ELDN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-10.92%

3 months

-8.74%

1 year

35.50%

2 years

28.86%

5 years

-47.41%

10 years

-98.39%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ELDN

Valuation

P/E

-6.10

Sector -4.38

Industry -4.38

P/BV

12.38

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-15,996.50

Sector -263.09

Industry -263.09

EV/EBIT

-15,996.50

Sector -702.90

Industry -702.90

P/EBITDA

-6.63

Sector -4.39

Industry -4.39

P/EBIT

-6.62

Sector -4.73

Industry -4.73

P/Total Assets

3.24

Sector 1.49

Industry 1.49

P/Net Current Assets

40,869.00

Sector -11.70

Industry -11.70

P/Working Capital

5.03

Sector -3.19

Industry -3.19

EPS

-0.59

Sector -2.14

Industry -2.14

BVPS

0.29

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-202.85%

Sector -65.14%

Industry -65.14%

ROA

-53.10%

Sector -65.53%

Industry -65.53%

ROIC

-0.26%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

7.90

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4,438.00

Sector -6.07

Industry -6.07

Net Debt / EBIT

4,438.00

Sector -8.26

Industry -8.26

Net Debt / Equity

-2.69

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.26

Sector 0.41

Industry 0.41

Liabilities/Assets

0.74

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

14.18%

Sector -

Industry -

Fundamentals ELDN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ELDN Eledon Pharmaceuticals Inc.	$3.55	36.80%	0.00%	-6.10	12.38	-202.85%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ELDN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Eledon Pharmaceuticals

Eledon Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

22 years

Founded: 2004

2014

Time since IPO - 12 years

10

Employees

Eledon Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $408.69 million, with shareholders equity totaling $33.01 million.

The company employs approximately 10 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Eledon Pharmaceuticals Inc. reported $- in revenue, generating net income of $-66.96 million.

Key financial metrics include a P/E ratio of -6.10, a price-to-book (P/B) ratio of 12.38, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ELDN.

Market cap

$408.69 million

Net worth

$33.01 million

$33,010,000.00

Assets

$126.09 million

$126,090,000.00

Total Shares Outstanding

114.00 million

114,000,000

Average Daily Trading Volume

$1.36 million

$1,364,269.32

Sector

Health Care

Industry

Biotechnology

ELDN

ELDN revenue and profits

Financial Results ELDN

DRAG THE FRAME TO SEE MORE DATA

ELDN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Eledon Pharmaceuticals (ELDN) today?

A cotação de Eledon Pharmaceuticals (ELDN) hoje está em US$ 3.55, com uma variação de 35.5% em relação ao último ano. A cotação de Eledon Pharmaceuticals (ELDN) iniciou o ano negociando na casa dos US$ 1.51 e hoje está em US$ 3.55. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Eledon Pharmaceuticals (ELDN) e dados de ações do Ibovespa e mercados internacionais.

Quando Eledon Pharmaceuticals (ELDN) paga dividendos?

Eledon Pharmaceuticals (ELDN) não distribuiu dividendos no último ano.

Is Eledon Pharmaceuticals (ELDN) a good investment?

Atualmente, Eledon Pharmaceuticals (ELDN) está cotada a US$ 3.55, com um P/L de -6.10, representando um desvio de -383% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 35.5 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 35.50%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Eledon Pharmaceuticals (ELDN) stock?

Investir em ações de Eledon Pharmaceuticals (ELDN) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Eledon Pharmaceuticals (ELDN) yield today?

A rentabilidade de Eledon Pharmaceuticals (ELDN) foi de -10.92% no último mês, 35.50% no último ano e -47.41% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Eledon Pharmaceuticals (ELDN) hoje, o investimento total seria de US$ 355.00, com base na cotação atual de US$ 3.55.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 481.03
Em 5 anos: US$ 186.69
Em 10 anos: US$ 5.72

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ELDN

Eledon Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ELDN

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ELDN WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Eledon Pharmaceuticals

Eledon Pharmaceuticals Inc.

United States

22 years

2014

10

PROFIT X PRICE ELDN

Financial Results ELDN

ELDN cash flow

Asset, Revenue and Profit Growth - ELDN

ELDN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions